RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
On April 29, 2014, ceritinib (Zykadia) was granted accelerated approval for treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic nonâsmall cell lung cancer (NSCLC) with disease progression on or intolerance to crizotinib (Xalkori).n April 29, 2014, ceritinib (Zykadia) was granted accelerated approval for treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic nonâsmall cell lung cancer (NSCLC) with disease progression on or intolerance to crizotinib (Xalkori).